MCL1 expression can be regulated at many levels, including via control transcription, translation and protein degradation, and it is currently unknown to what extent increased MCL1 mRNA translation contributes to accumulation of MCL1 protein in anti-IgM-stimulated CLL cells. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.